Testimony & Official Correspondence

EWG Letter to FDA regarding Melamine

Friday, May 25, 2007

May 4, 2007

Dr. David Acheson
Assistant Commissioner for Food Protection
U.S. Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland 20857

Dear Dr. Acheson:

Statement of Anila Jacob, MD, MPH

Thursday, November 8, 2007

Senior Scientist

Environmental Working Group

Hearing on Perchlorate: Health and Environmental Impacts of Unregulated Exposure

Before the House of Representatives

Subcommittee on Environment and Hazardous Materials of the Committee on Energy and Commerce

Wednesday, April 25, 2007, at 10 am

Submitted for the Record

EWG Letter to EPA Administrator Johnson Regarding Perchlorate

Monday, May 28, 2007

Download the PDF of this letter.

March 29, 2007

Stephen L. Johnson
Administrator
U.S. Environmental Protection Agency
Ariel Rios Building
1200 Pennsylvania Avenue, N.W.
Washington, D.C. 20460

Dear Administrator Johnson,

EWG Letter to Panel

Monday, July 2, 2007

February 28, 2007

David A. Schwartz, M.D.
Director
National Toxicology Program
National Institute of Environmental Health Sciences
P.O. Box 12233
Research Triangle Park, NC 27709
Fax: 919.541.2260

Dear Dr. Schwartz,

EWG Letter to EPA

Friday, May 18, 2007

January 4, 2007

Mr. Jim Jones, Director
Office of Pesticide Programs
Environmental Protection Agency
Mail Code 7510P
1200 Pennsylvania Avenue, NW
Washington, DC 20460-0001

Dear Mr. Jones,

EWG Letter to Harvard President Bok

Sunday, June 3, 2007

42 CFR Parts 50 and 93 [PDF]

October 11, 2006

Derek Bok, J.D.
President
Harvard University
Massachusetts Hall
Cambridge, MA 02138 USA

Dear President Bok:

EWG Letter to Harvard President Bok

Thursday, May 17, 2007

October 11, 2006

Derek Bok, J.D.
President
Harvard University
Massachusetts Hall
Cambridge, MA 02138 USA

Dear President Bok:

Action Alert: Sign Onto Our Letter

Tuesday, October 2, 2007

Comments to U.S. Food and Drug Administration
Docket: FDA Regulated Products Containing Nanotechnology Materials
Docket number: 2006N-0107

Tell FDA: No nanotech until we know it is safe

Sign onto our letter, and we'll add your name to the list of those who support EWG's campaign to ensure the safety of nanotech in personal care products.

Key Issues:

Cosmetics

EWG Comments to FDA on Nano-Scale Ingredients in Cosmetics

Tuesday, October 10, 2006

EWG submits comments to FDA on the need for a public process to identify and evaluate the safety of nanomaterials in cosmetics. Recommendations to FDA include the need to identify nano-scale materials in personal care products and complete product safety evaluations in those cases.

Key Issues:

Harvard: Prof Did Not "Intentionally" Suppress Fluoride-Cancer Study

Sunday, June 3, 2007

(WASHINGTON, Aug. 16) — A closed-door Harvard University panel said yesterday that professor Chester Douglass "did not intentionally omit, misrepresent or suppress research results" of a fluoride bone cancer study. But Environmental Working Group (EWG), whose questions triggered the investigation, said the panel's brief statement sidestepped the question of whether Douglass did in fact omit, misrepresent, or suppress critical data that show a strong link between bone cancer in adolescent boys and fluoride in tap water.

Key Issues: